
To explore the preoperative utility of FDG PET for the diagnosis and prognosis in a retrospective breast cancer case series.In this retrospective study, 104 patients who had undergone a preoperative FDG PET scan for primary breast cancer at the UZ Brussel during the period 2002-2008 were identified. Selection criteria were: histological confirmation, FDG PET performed prior to therapy, and breast surgery integrated into the primary therapy plan. Patterns of increased metabolism were recorded according to the involved locations: breast, ipsilateral axillary region, internal mammary chain, or distant organs. The end-point for the survival analysis using Cox proportional hazards was disease-free survival. The contribution of prognostic factors was evaluated using the Akaike information criterion and the Nagelkerke index.PET positivity was associated with age, gender, tumour location, tumour size >2 cm, lymphovascular invasion, oestrogen and progesterone receptor status. Among 63 patients with a negative axillary PET status, 56 (88.9 %) had three or fewer involved nodes, whereas among 41 patients with a positive axillary PET status, 25 (61.0 %) had more than three positive nodes (P < 0.0001). In the survival analysis of preoperative characteristics, PET axillary node positivity was the foremost statistically significant factor associated with decreased disease-free survival (hazard ratio 2.81, 95% CI 1.17-6.74).Preoperative PET axillary node positivity identified patients with a higher burden of nodal involvement, which might be important for treatment decisions in breast cancer patients.
Adult, Male, 616.0757, Breast Neoplasms, Male/radionuclide imaging/surgery, Middle Aged, Prognosis, Breast Neoplasms, Male, 618, evaluation studies, Fluorodeoxyglucose F18/diagnostic use, Fluorodeoxyglucose F18, Lymphatic Metastasis, Positron-Emission Tomography, Preoperative Care, breast neoplasms, Humans, Radiopharmaceuticals/diagnostic use, Female, Radiopharmaceuticals, Retrospective Studies, ddc: ddc:618, ddc: ddc:616.0757
Adult, Male, 616.0757, Breast Neoplasms, Male/radionuclide imaging/surgery, Middle Aged, Prognosis, Breast Neoplasms, Male, 618, evaluation studies, Fluorodeoxyglucose F18/diagnostic use, Fluorodeoxyglucose F18, Lymphatic Metastasis, Positron-Emission Tomography, Preoperative Care, breast neoplasms, Humans, Radiopharmaceuticals/diagnostic use, Female, Radiopharmaceuticals, Retrospective Studies, ddc: ddc:618, ddc: ddc:616.0757
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 16 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
